Abortion in First TrimesterNCT05182008
A Patient Decision Aid for Method of Early Abortion: a Randomized Control Trial
A study testing Decision aid in people with Abortion in First Trimester and Abortion Early, run by Nova Scotia Health Authority at 1 site in Canada.
Trial summary
Introduction: There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. When making a decision about which option is best for them, patient must consider their values as well as social resources and circumstances Patient decision aids (PtDAs) are tools to… Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Abortion in First Trimester, Abortion Early, Decision Aid
- What is being tested?
- Decision aid
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 365 participants
- Where
- 1 siteCanada
- Study dates
- 5 May 2022to 1 Apr 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- person of reproductive age seeking termination of pregnancy, felt to be within the eligible period for a medication abortion (<9 weeks or 63 days from last menstrual period), can provide consent, has access to internet and a valid email address and be able to read and speak English.
Who cannot join
- Participants will be excluded from the four week follow up survey if they are subsequently found to be ineligible for medication abortion (pregnancy too advanced or if there are medical contraindications), if they miscarry spontaneously, or choose to continue their pregnancy.
Trial locations and contacts
1 site in 1 country.
About this study
Introduction: There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. When making a decision about which option is best for them, patient must consider their values as well as social resources and circumstances Patient decision aids (PtDAs) are tools to help patients make health-related decisions, particularly when no 'best' choice exist.
Our research team has developed an online interactive patient decision aid on method of abortion based on international standards for decision aid development. We would like to investigate whether it leads to improved decisional quality in patients seeking early abortion.
Read more
Methods: Phase 1 will be development of an abortion knowledge assessment tool. We will start by developing ten multiple choice questions based on information that is classically included in abortion education material. The goal is to ultimately include 5-7 well-performing questions in the trial. The ten questions will be sent to content experts to answer and rate. They will rate the questions on representativeness and importance. The questions will also be administered to community members without specific abortion knowledge. Results will be used to assess content validity and discriminator validity and revise the questionnaire.
Phase 2 will be a randomized trial of people seeking abortion at less than 63 days gestation. Those who wish to participate will be randomized either the decision aid (study group) or the standard abortion clinic website (control). They will then be asked to participate in a survey immediately after they are finished reviewing the decision aid or website to. This survey will include questions about their decision, demographics, medical history, and their level of knowledge about abortion methods (by administering the knowledge assessment tool described above). The evaluation of the decision making will be measured using the Decisional Conflict Score. Four weeks post procedure, participants will be contacted by e-mail again and asked to complete a second survey identifying which type of abortion they underwent along with an inventory of perceived adverse treatment effects, as well as completing a Satisfaction with Decision Scale (SWD)
Read the detailed description
There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. Each offers unique benefits and drawback. When making a decision about which option is best for them, patient must consider their values as well as social resources and circumstances. These decisions must be made quickly because of the time sensitive nature of abortion. Research has shown that people seeking abortion value making an informed decision on method.
Patient decision aids (PtDAs) are tools to help patients make health-related decisions, particularly when no 'best' choice exist. Research shows that in comparison to usual care, decision aids have been shown to improve patient knowledge and risk perception, reduce decisional conflict, and promote shared decision making and value-congruent decisions (i.e. decisions that are in alignment with the patients stated values and priorities) Our research team has developed an online interactive patient decision aid on method of abortion based on international standards for decision aid development. We would like to investigate whether it leads to improved decisional quality in patients seeking early abortion.
Phase 1 will be development of an abortion knowledge assessment tool. This tool will be used in Phase 2 of the study to evaluate decision quality. We will start by developing ten multiple choice questions based on information that is classically included in abortion education material. The goal is to ultimately include 5-7 well-performing questions in the trial. The ten questions will be sent to content experts to answer and rate. They will rate the questions on representativeness (Overall how well does this question represent key facts that a patient should know before deciding about abortion method?) and importance (How important is this question for patients to understand to be considered informed?). The questions will also be administered to community members without specific abortion knowledge. Based on data from these surveys the questions will be revised. To ensure content validity, only questions the experts rate as sufficiently representative and important will be included. Discriminant validity will be evaluated by comparing the scores of content experts to those of community members. Only questions with adequate discriminant validity will be included. Content experts will be persons known to the primary investigator and will be recruited directly. Community members will be recruited online though social media (eg. Facebook). Both content experts and community members will complete an online consent form and online survey.
Phase 2 of the study will be integrated into the standard workflow of the Nova Scotia Women's Clinic. Patients are able to self refer to the clinic and during the initial intake phone call, they will be asked if they can be contacted by the research coordinator to discuss study participation. Those who agree will be contacted by the research coordinator to review the study and patients will be ask if they would like to participate in the they study. Those who wish to participate will be randomized and e-mailed a weblink to an online consent form and either the decision aid (study group) or the standard NSWCC website (control). Participants will be randomized in a 1:1 ratio within blocks of size 2, 4, and 6 (in random order). To further ensure the randomization is concealed, a statistician who is not on the study team will generate the sequence using the R package, blockrand. They will then be asked to participate in a survey immediately after they are finished reviewing the decision aid or website to. This survey will include questions about their decision, demographic information, medical history,and their level of knowledge about abortion methods (by administering the knowledge assessment tool described above). The evaluation of the decision making will be measured using the Decisional Conflict Score, which measures the quality of the decision making process and consist of question for which patients rate their experiences on a scale of strongly agree or disagree. Four weeks post procedure, participants will be contacted by e-mail again and asked to complete a second survey identifying which type of abortion they underwent along with an inventory of perceived adverse treatment effects, as well as completing a Satisfaction with Decision Scale (SWD)
- Conditions
- Abortion in First Trimester, Abortion Early, Decision Aid, Clinical Decision-making, Abortion, Therapeutic
- Being tested
- Decision aid, Usual care
- Keywords
- Abortion, Decision aid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Decision aidOther
Online interactive decision aid on method of early abortion
Usual careOther
Patients will be directed to the abortion clinic website
| Study group | Role | What they receive |
|---|---|---|
| Decision Aid | Experimental | Patients will be guided to an online interactive decision aid tool. Receives: Other: Decision aid |
| Usual Care | Active comparator | Patients will be guided to visit the clinic website of the Nova Scotia Women's Choice Clinic. Receives: Other: Usual care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Decisional Conflict Score
The DCS consists of 16 statements that participants rate from "strongly agree" [0] to "strongly disagree" [4]; scores are summed, divided by 16, and multiplied by 25 (for a score out of 100). High scores indicate greater decisional conflict.
Measured: Immediately after use of intervention (decision aid) or usual care condition (clinic website)
Secondary outcomes (3)
Satisfaction with decision score (SWD)
A six-item attitude Likert scale that has been shown to be a reliable and valid measure of patients' satisfaction with their healthcare-related decisions. It is rated on a 1-5 scale (1= strongly disagree; 5 = strongly agree). Higher scores indicate higher satisfaction with decision.
Measured: 4 weeks after enrolment (after abortion complete)
Decision concordance
Decision concordance will be calculated by comparing the stated decision preference at time 0 (for those who express a preference) to the actual method chosen by each patient as measured 4 weeks later. It will be expressed at a percentage.
Measured: 4 weeks after enrolment (after abortion complete)
Knowledge of abortion method score
The knowledge score will be calculated by dividing the number of correct answers by the total number of questions and multiplied by 100 (percentage correct).
Measured: Immediately after use of intervention (decision aid) or usual care condition (clinic website)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jan 2022
- Study start5 May 2022
- Primary completion1 Mar 2024
- Study completion1 Apr 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Abortion in First TrimesterStudies of the same condition, open and under way.
- More trials run by Nova Scotia Health AuthorityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 365 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nova Scotia Health Authority
- Sponsor type
- University, hospital or other
- Collaborators
- Dalhousie University, University of British Columbia, IWK Health Centre
- Responsible party
- Principal investigator, Melissa Brooks, Nova Scotia Health Authority
- Investigators
- Melissa Brooks, Principal investigator, Dalhousie University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05182008
- Sponsor's protocol ID
- NSHA43377
- Status last verified
- Feb 2025
- First submitted
- 12 Dec 2021
- Last updated
- 21 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Patient Decision Aid for Method of Early Abortion: a Randomized Control Trial
- ClinicalTrials.gov ID
- NCT05182008
- Acronym / sponsor ID
- NSHA43377
- Conditions
- Abortion in First Trimester, Abortion Early, Decision Aid, Clinical Decision-making, Abortion, Therapeutic
- Keywords
- Abortion, Decision aid
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 365 participants (actual)
- Lead sponsor
- Nova Scotia Health AuthorityUniversity, hospital or other
- Collaborators
- Dalhousie University, University of British Columbia, IWK Health Centre
- Study start
- 5 May 2022 (actual)
- Primary completion
- 1 Mar 2024 (actual)
- Study completion
- 1 Apr 2024 (actual)
- First posted
- 10 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction: There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. When making a decision about which option is best for them, patient must consider their values as well as social resources and circumstances Patient decision aids (PtDAs) are tools to help patients make health-related decisions, particularly when no 'best' choice exist.
Our research team has developed an online interactive patient decision aid on method of abortion based on international standards for decision aid development. We would like to investigate whether it leads to improved decisional quality in patients seeking early abortion.
Methods: Phase 1 will be development of an abortion knowledge assessment tool. We will start by developing ten multiple choice questions based on information that is classically included in abortion education material. The goal is to ultimately include 5-7 well-performing questions in the trial. The ten questions will be sent to content experts to answer and rate. They will rate the questions on representativeness and importance. The questions will also be administered to community members without specific abortion knowledge. Results will be used to assess content validity and discriminator validity and revise the questionnaire.
Phase 2 will be a randomized trial of people seeking abortion at less than 63 days gestation. Those who wish to participate will be randomized either the decision aid (study group) or the standard abortion clinic website (control). They will then be asked to participate in a survey immediately after they are finished reviewing the decision aid or website to. This survey will include questions about their decision, demographics, medical history, and their level of knowledge about abortion methods (by administering the knowledge assessment tool described above). The evaluation of the decision making will be measured using the Decisional Conflict Score. Four weeks post procedure, participants will be contacted by e-mail again and asked to complete a second survey identifying which type of abortion they underwent along with an inventory of perceived adverse treatment effects, as well as completing a Satisfaction with Decision Scale (SWD)
Detailed description
There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. Each offers unique benefits and drawback. When making a decision about which option is best for them, patient must consider their values as well as social resources and circumstances. These decisions must be made quickly because of the time sensitive nature of abortion. Research has shown that people seeking abortion value making an informed decision on method.
Patient decision aids (PtDAs) are tools to help patients make health-related decisions, particularly when no 'best' choice exist. Research shows that in comparison to usual care, decision aids have been shown to improve patient knowledge and risk perception, reduce decisional conflict, and promote shared decision making and value-congruent decisions (i.e. decisions that are in alignment with the patients stated values and priorities) Our research team has developed an online interactive patient decision aid on method of abortion based on international standards for decision aid development. We would like to investigate whether it leads to improved decisional quality in patients seeking early abortion.
Phase 1 will be development of an abortion knowledge assessment tool. This tool will be used in Phase 2 of the study to evaluate decision quality. We will start by developing ten multiple choice questions based on information that is classically included in abortion education material. The goal is to ultimately include 5-7 well-performing questions in the trial. The ten questions will be sent to content experts to answer and rate. They will rate the questions on representativeness (Overall how well does this question represent key facts that a patient should know before deciding about abortion method?) and importance (How important is this question for patients to understand to be considered informed?). The questions will also be administered to community members without specific abortion knowledge. Based on data from these surveys the questions will be revised. To ensure content validity, only questions the experts rate as sufficiently representative and important will be included. Discriminant validity will be evaluated by comparing the scores of content experts to those of community members. Only questions with adequate discriminant validity will be included. Content experts will be persons known to the primary investigator and will be recruited directly. Community members will be recruited online though social media (eg. Facebook). Both content experts and community members will complete an online consent form and online survey.
Phase 2 of the study will be integrated into the standard workflow of the Nova Scotia Women's Clinic. Patients are able to self refer to the clinic and during the initial intake phone call, they will be asked if they can be contacted by the research coordinator to discuss study participation. Those who agree will be contacted by the research coordinator to review the study and patients will be ask if they would like to participate in the they study. Those who wish to participate will be randomized and e-mailed a weblink to an online consent form and either the decision aid (study group) or the standard NSWCC website (control). Participants will be randomized in a 1:1 ratio within blocks of size 2, 4, and 6 (in random order). To further ensure the randomization is concealed, a statistician who is not on the study team will generate the sequence using the R package, blockrand. They will then be asked to participate in a survey immediately after they are finished reviewing the decision aid or website to. This survey will include questions about their decision, demographic information, medical history,and their level of knowledge about abortion methods (by administering the knowledge assessment tool described above). The evaluation of the decision making will be measured using the Decisional Conflict Score, which measures the quality of the decision making process and consist of question for which patients rate their experiences on a scale of strongly agree or disagree. Four weeks post procedure, participants will be contacted by e-mail again and asked to complete a second survey identifying which type of abortion they underwent along with an inventory of perceived adverse treatment effects, as well as completing a Satisfaction with Decision Scale (SWD)
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Decision Aid | Experimental | Other: Decision aidPatients will be guided to an online interactive decision aid tool. |
| Usual Care | Active comparator | Other: Usual carePatients will be guided to visit the clinic website of the Nova Scotia Women's Choice Clinic. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- person of reproductive age seeking termination of pregnancy, felt to be within the eligible period for a medication abortion (<9 weeks or 63 days from last menstrual period), can provide consent, has access to internet and a valid email address and be able to read and speak English.
Key exclusion criteria (1 listed)
- Participants will be excluded from the four week follow up survey if they are subsequently found to be ineligible for medication abortion (pregnancy too advanced or if there are medical contraindications), if they miscarry spontaneously, or choose to continue their pregnancy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Decision aidOnline interactive decision aid on method of early abortion | Other | Decision Aid |
| Usual carePatients will be directed to the abortion clinic website | Other | Usual Care |
Primary outcome
Decisional Conflict Score
Time frame: Immediately after use of intervention (decision aid) or usual care condition (clinic website)
The DCS consists of 16 statements that participants rate from "strongly agree" [0] to "strongly disagree" [4]; scores are summed, divided by 16, and multiplied by 25 (for a score out of 100). High scores indicate greater decisional conflict.
3 secondary outcomes
Satisfaction with decision score (SWD)
Time frame: 4 weeks after enrolment (after abortion complete)
Decision concordance
Time frame: 4 weeks after enrolment (after abortion complete)
Knowledge of abortion method score
Time frame: Immediately after use of intervention (decision aid) or usual care condition (clinic website)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Feb 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Abortion in First Trimester
Not yet recruitingObservational study
Predictors of Successful Office Operative Hysteroscopy Using a Mini-Resectoscope
Retained Products of Conception, Hysteroscopy
RecruitingObservational study
Research on Equity in Abortion Care by TeleHealth
Abortion in First Trimester, Abortion Early
Recruiting
GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA
Miscarriage in First Trimester, Prenatal Genetic Diagnosis
Not yet recruiting
GPT-Based Digital Assistant Support During Treatment for Induced Abortion or Missed Abortion
Missed Abortion, Early Pregnancy Loss
Not yet recruiting
Cost-utility Analysis of Outpatient Manual Vacuum Aspiration Versus Operating Room Electric Aspiration for the Management of First-trimester Miscarriage
Miscarriage, Pregnancy Loss
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Melissa Brooks principal investigator
Dalhousie University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Decision aid in people with Abortion in First Trimester and Abortion Early, run by Nova Scotia Health Authority at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Decisional Conflict Score (time frame: Immediately after use of intervention (decision aid) or usual care condition (clinic website)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2025; AzTrials last refreshed its copy on 7 Nov 2026.